Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Intratumoral Administration of L19IL2/L19TNF in Non-melanoma Skin Cancer Patients With Presence of Injectable Lesions

NCT04362722 is registered in ClinicalTrials.gov with Philogen S.p.A. as lead sponsor.

NCT NCT04362722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04362722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Intratumoral Administration of L19IL2/L19TNF in Non-melanoma Skin Cancer Patients With Presence of Injectable Lesions
Lead sponsor
Philogen S.p.A.
Phase
Phase 2
Overall status
Unknown status
Start date
September 2, 2020
Completion date
September 30, 2024
Enrollment
40 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell, carcinoma, cutaneous squamous cell